Q: What is Remicade used for?

Remicade is used to treat: Crohn's disease Ulcerative colitis Rheumatoid arthritis Others

Q: How does Remicade work?

Mechanism of Action Remicade (infliximab) belongs to a class of medications known as tumor necrosis factor (TNF) blockers. It is a monoclonal antibody, which is a type of protein designed to recognize and bind to a specific target in the body. The primary target of Remicade is a protein called tumor necrosis factor-alpha (TNF-alpha). In a healthy body, TNF-alpha is produced by the immune system to help regulate inflammation. However, in people with certain autoimmune diseases, the body produces excessive amounts of this protein. High levels of TNF-alpha lead to several issues, including: Persistent inflammation in various tissues, such as the joints, skin, or digestive tract. Damage to healthy organs and tissues. Symptoms like pain, swelling, and stiffness. When Remicade is administered, it circulates in the bloodstream and attaches itself to TNF-alpha. By binding to this protein, Remicade prevents it from reaching the receptors on cells that would normally trigger an inflammatory response. This action helps to lower inflammation, manage symptoms, and potentially prevent further tissue damage caused by the overactive immune system.

Q: What are the active ingredients in Remicade?

The active ingredient in Remicade is infliximab .

Q: What are the side effects of Remicade?

Common side effects of Remicade may include: upper respiratory tract infection headache infusion reactions Always consult with a healthcare professional about potential side effects.

Q: What drug class is Remicade?

Remicade belongs to the TNF inhibitor drug class.

Q: What is the dosage of Remicade and how do I take it?

How Remicade is Administered Remicade is given as an injection into a vein, known as an intravenous (IV) infusion. This procedure must be performed by a healthcare professional in a hospital, clinic, or doctor's office. The infusion process takes a period of time to complete. During and after the procedure, medical staff will monitor you closely for any signs of a reaction to the medication. Treatment Schedule The frequency of your treatments depends on the specific condition being treated and how your body responds to the medication. Generally, the treatment follows a specific pattern: Induction Phase: You will receive several initial doses over the first few weeks of treatment. Maintenance Phase: After the initial doses, you will receive regular infusions, typically every several weeks. Missed Doses It is important to receive every scheduled infusion. If you miss an appointment for your Remicade treatment, contact your healthcare provider immediately to reschedule. Keeping a consistent schedule helps ensure the medication remains effective.

Q: Is Remicade safe during pregnancy and breastfeeding?

Pregnancy Research on the use of Remicade during pregnancy has not shown an increased risk of major birth defects. However, the medication is known to cross the placenta, particularly during the third trimester. This means the baby may be born with the medication in their system, which could affect their immune system's ability to fight infections. If you received Remicade during pregnancy, it is important to inform your child's pediatrician. Infants exposed to this medication in the womb should generally not receive live vaccines (such as the rotavirus vaccine) for at least six months after birth, as their immune system may be temporarily suppressed. Breastfeeding Remicade passes into breast milk in very small amounts. While current evidence suggests that it is unlikely to cause harm to a nursing infant, you should discuss the risks and benefits with your healthcare provider before breastfeeding while using this medication.

Q: What forms and strengths does Remicade come in?

Dosage Forms Remicade is available in the following form: Powder for Injection: This is a sterile, preservative-free, lyophilized powder provided in a single-dose vial. Administration Method This medication is not taken by mouth or self-injected at home. Instead, it is prepared by a healthcare provider and given as an intravenous infusion. This process involves dripping the medicine slowly into a vein, usually in the arm, over a period of time in a clinical setting.

Q: What is the FDA approval status of Remicade?

FDA Approval and Indications Remicade (infliximab) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of various autoimmune and inflammatory disorders. It is indicated for use in both adults and children for certain conditions, including: Crohn's disease (adults and children 6 years and older) Ulcerative colitis (adults and children 6 years and older) Rheumatoid arthritis (in combination with methotrexate) Ankylosing spondylitis Psoriatic arthritis Chronic severe plaque psoriasis Boxed Warning The FDA has issued a boxed warning for Remicade due to the risk of serious infections and malignancy. Because Remicade affects the immune system, it can lower the body's ability to fight infections. Reported serious infections include tuberculosis (TB), bacterial sepsis, and invasive fungal infections. Patients must be tested for latent TB before starting treatment and monitored for active TB during therapy. There is also an increased risk of lymphoma and other cancers in children and adolescent patients treated with TNF blockers like Remicade. Specifically, cases of hepatosplenic T-cell lymphoma, a rare and often fatal cancer, have occurred in young adults and children with inflammatory bowel disease who were also taking other immunosuppressive medications. Regulatory Monitoring The FDA requires healthcare providers to monitor patients closely for signs of infection or malignancy during and after treatment. Patients are advised to seek medical attention immediately if they develop symptoms such as fever, persistent cough, or unusual weight loss. The medication is administered via intravenous infusion, typically in a clinical setting where patients can be monitored for immediate infusion reactions.

Question 1

What is Remicade?

Accepted Answer

Remicade is a type of medicine known as a tumor necrosis factor (TNF) inhibitor. It works by targeting and neutralizing TNF-alpha, a protein produced by the immune system that can cause excessive inflammation when present in high levels.

By blocking this protein, the medication helps to decrease the body's inflammatory response. This action helps manage chronic conditions where the immune system mistakenly attacks healthy tissues.

Question 2

What is Remicade used for?

Accepted Answer

Remicade is used to treat:

Crohn's disease
Ulcerative colitis
Rheumatoid arthritis
Others

Question 3

How does Remicade work?

Accepted Answer

Mechanism of Action

Remicade (infliximab) belongs to a class of medications known as tumor necrosis factor (TNF) blockers. It is a monoclonal antibody, which is a type of protein designed to recognize and bind to a specific target in the body.

The primary target of Remicade is a protein called tumor necrosis factor-alpha (TNF-alpha). In a healthy body, TNF-alpha is produced by the immune system to help regulate inflammation. However, in people with certain autoimmune diseases, the body produces excessive amounts of this protein.

High levels of TNF-alpha lead to several issues, including:

Persistent inflammation in various tissues, such as the joints, skin, or digestive tract.
Damage to healthy organs and tissues.
Symptoms like pain, swelling, and stiffness.

When Remicade is administered, it circulates in the bloodstream and attaches itself to TNF-alpha. By binding to this protein, Remicade prevents it from reaching the receptors on cells that would normally trigger an inflammatory response. This action helps to lower inflammation, manage symptoms, and potentially prevent further tissue damage caused by the overactive immune system.

Question 4

What are the active ingredients in Remicade?

Accepted Answer

The active ingredient in Remicade is infliximab.

Question 5

What are the side effects of Remicade?

Accepted Answer

Common side effects of Remicade may include:

upper respiratory tract infection
headache
infusion reactions

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Remicade?

Accepted Answer

Remicade belongs to the TNF inhibitor drug class.

Question 7

What is the dosage of Remicade and how do I take it?

Accepted Answer

How Remicade is Administered

Remicade is given as an injection into a vein, known as an intravenous (IV) infusion. This procedure must be performed by a healthcare professional in a hospital, clinic, or doctor's office.

The infusion process takes a period of time to complete. During and after the procedure, medical staff will monitor you closely for any signs of a reaction to the medication.

Treatment Schedule

The frequency of your treatments depends on the specific condition being treated and how your body responds to the medication. Generally, the treatment follows a specific pattern:

Induction Phase: You will receive several initial doses over the first few weeks of treatment.
Maintenance Phase: After the initial doses, you will receive regular infusions, typically every several weeks.

Missed Doses

It is important to receive every scheduled infusion. If you miss an appointment for your Remicade treatment, contact your healthcare provider immediately to reschedule. Keeping a consistent schedule helps ensure the medication remains effective.

Question 8

Is Remicade safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Research on the use of Remicade during pregnancy has not shown an increased risk of major birth defects. However, the medication is known to cross the placenta, particularly during the third trimester. This means the baby may be born with the medication in their system, which could affect their immune system's ability to fight infections.

If you received Remicade during pregnancy, it is important to inform your child's pediatrician. Infants exposed to this medication in the womb should generally not receive live vaccines (such as the rotavirus vaccine) for at least six months after birth, as their immune system may be temporarily suppressed.

Breastfeeding

Remicade passes into breast milk in very small amounts. While current evidence suggests that it is unlikely to cause harm to a nursing infant, you should discuss the risks and benefits with your healthcare provider before breastfeeding while using this medication.

Question 9

What forms and strengths does Remicade come in?

Accepted Answer

Dosage Forms

Remicade is available in the following form:

Powder for Injection: This is a sterile, preservative-free, lyophilized powder provided in a single-dose vial.

Administration Method

This medication is not taken by mouth or self-injected at home. Instead, it is prepared by a healthcare provider and given as an intravenous infusion. This process involves dripping the medicine slowly into a vein, usually in the arm, over a period of time in a clinical setting.

Question 10

What is the FDA approval status of Remicade?

Accepted Answer

FDA Approval and Indications

Remicade (infliximab) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of various autoimmune and inflammatory disorders. It is indicated for use in both adults and children for certain conditions, including:

Crohn's disease (adults and children 6 years and older)
Ulcerative colitis (adults and children 6 years and older)
Rheumatoid arthritis (in combination with methotrexate)
Ankylosing spondylitis
Psoriatic arthritis
Chronic severe plaque psoriasis

Boxed Warning

The FDA has issued a boxed warning for Remicade due to the risk of serious infections and malignancy. Because Remicade affects the immune system, it can lower the body's ability to fight infections. Reported serious infections include tuberculosis (TB), bacterial sepsis, and invasive fungal infections. Patients must be tested for latent TB before starting treatment and monitored for active TB during therapy.

There is also an increased risk of lymphoma and other cancers in children and adolescent patients treated with TNF blockers like Remicade. Specifically, cases of hepatosplenic T-cell lymphoma, a rare and often fatal cancer, have occurred in young adults and children with inflammatory bowel disease who were also taking other immunosuppressive medications.

Regulatory Monitoring

The FDA requires healthcare providers to monitor patients closely for signs of infection or malignancy during and after treatment. Patients are advised to seek medical attention immediately if they develop symptoms such as fever, persistent cough, or unusual weight loss. The medication is administered via intravenous infusion, typically in a clinical setting where patients can be monitored for immediate infusion reactions.

Question 11

What should I know about Remicade and infusion?

Accepted Answer

The Infusion Process

Remicade is not available as a self-injection. It must be given through a needle placed into a vein, usually in the arm, by a doctor or nurse. This process is called an intravenous infusion and is performed in a hospital, clinic, or specialized infusion center.

Timing and Schedule

A standard infusion usually lasts about two hours. After the initial dose, the medication is typically given again at two weeks and six weeks. Following these three starting doses, maintenance infusions are usually scheduled every six or eight weeks, depending on the condition being treated.

Preparation and Monitoring

To help prevent infusion reactions, a healthcare provider may give other medications before the Remicade infusion starts, such as:

Antihistamines
Acetaminophen
Corticosteroids

During the infusion and for a period of time afterward, medical staff will monitor for signs of a reaction, such as changes in blood pressure or heart rate. If a reaction occurs, the infusion may be slowed down or stopped.

Potential Infusion Reactions

Some patients experience side effects during or shortly after the infusion. It is important to notify a healthcare provider immediately if any of the following occur:

Fever or chills
Chest pain
Shortness of breath
Itching or hives
Flushing or sweating
Nausea or headache

Remicade

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Remicade

Hospitals.net Disclosure